03.07.2019 • News

Brenntag B&M Buy Boosts US Lubricants

Brenntag B&M Buy Boosts US Lubricants
Brenntag B&M Buy Boosts US Lubricants

Leading distributor Brenntag has once again boosted its lubricants business with the acquisition of US-based B&M Oil.

Headquartered in Tulsa, Oklahoma, B&M markets, sells and distributes lubricants to the automotive, industrial, commercial, construction and agriculture markets throughout Oklahoma. The company primarily distributes products from ExxonMobil, including Mobil-branded lubricants for both passenger and commercial vehicles and industrial uses.

“B&M is a bolt on acquisition for J.A.M. Distributing, our Brenntag lubricants business platform in the central US region and will expand our offering in the growing Oklahoma marketplace,” said Markus Klaehn, member of Brenntag Group’s management board and CEO Brenntag North America.

B&M generated sales of $28.5 million in fiscal 2018. Financial terms of the transaction were not disclosed.

The deal marks Brenntag’s fourth acquisition in the US so far this year. In January 2019, the German group bought the lubricants division of Reeder Distributors, based in Fort Worth, Texas. This was followed in March by the takeover of New England Resins & Pigments, a regional distributor of specialty chemicals and packaging products.

Marlin then joined Brenntag in May. The Lenoir, North Carolina-based company provides custom chemical blending and packaging services for liquid and powder products to customers in the mid-south region of the US.

Other US lubricants businesses that Brenntag has purchased in recent years include NOCO and Mayes County Petroleum Products in October and September, 2016 respectively, and Lubrication Services in March 2013. 

 

#######

 

www.brenntag.com

Company

Logo:

Brenntag SE

Messeallee 11
45131 Essen
Germany

Company contact







Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

Interview

Navigating Uncertainty and Driving Innovation
Meeting Pharma’s Demand for Speed, Reliability, and Flexibility

Navigating Uncertainty and Driving Innovation

Axplora CCO Arul Ramadurai discusses navigating industry uncertainty, building strategic partnerships, and advancing flexible pharmaceutical manufacturing

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.